Abdominal Pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abdominal wall muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal behavior
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Here, we review the evidence for the crucial involvement of PTEN in neuronal injury as well as in neurological and psychiatric disorders, and discuss the potential of PTEN as a molecular target for the development of a novel CNS therapeutic strategy.
|
17959258 |
2007 |
Abnormal form of the vertebral bodies
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal large intestine morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal lung lobation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal subcutaneous fat tissue distribution
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of cardiovascular system morphology
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Vascular malformations have a prevalence of 19%, with further evidence that complex cardiovascular malformations may be related to PTEN mutations; 31% of patients present hamartomas.
|
30528446 |
2019 |
Abnormality of dental enamel
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Abnormality of retinal pigmentation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the cerebellum
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Abnormality of the fallopian tube
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the metacarpal bones
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the optic nerve
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the parathyroid gland
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the penis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the vasculature
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Abnormality of the wrist
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acinar Cell Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
We examined the status of RB1, TP53, and PTEN in prostatic small cell and acinar carcinomas via immunohistochemistry (IHC), copy-number alteration analysis, and sequencing of formalin-fixed paraffin-embedded specimens.
|
24323898 |
2014 |
Acinar Cell Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
No foci of HGPIN showed uniform PTEN loss; there was only 38% concordance of PTEN expression pattern between HGPIN and the nearby acinar carcinoma, unlike AIP and IDC (77% and 81%, respectively, P<0.01).
|
28009609 |
2017 |
Acoustic Neuroma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The maintained expression of the PTEN protein, together with the lack of detectable mutations in this gene, suggests that the function of the PTEN tumour suppressor gene is not altered in sporadic vestibular schwannomas.
|
12047763 |
2002 |
Acoustic Neuroma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Because PTEN regulates signaling through the growth-promoting phosphoinositide 3-kinase/AKT pathway, our findings suggest that miR-21 may be a suitable molecular target for therapies aimed specifically at reducing VS growth.
|
20856158 |
2010 |
Acquired genu recurvatum
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acquired Immunodeficiency Syndrome
|
0.010 |
AlteredExpression
|
group |
BEFREE |
To investigate mTOR pathway activity in acquired immunodeficiency syndrome (AIDS) related diffuse large B-cell lymphoma AR-DLBCL, we used immunohistochemistry to examine the presence of the phosphorylated 70 ribosomal S6 protein-kinase (p70S6K), an extensively studied effector of mTOR Complex 1 (mTORC1) and the phosphorylated phosphatase and tensin homolog (pPTEN), a negative regulator of mTORC1 pathway.
|
28192480 |
2017 |
Acral Lentiginous Malignant Melanoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Only one of the ALMs that were screened for PTEN harbored a mutation (4%).
|
23993026 |
2013 |